Fig. 3From: Identification of (−)-epigallocatechin (EGC) as a methylglyoxal (MGO)-trapping agent and thereby as an inhibitor of advanced glycation end product (AGE) formationComparison of MGO-trapping activity of EGC (3), EGCG (2), and quercetin (1) in different concentrations [(A) 0.25 mM, (B) 0.5 mM, (C) 1.5 mM, and (D) 2.5 mM]. Each value represents the mean ± SD (n = 3)Back to article page